OVERVIEW

2021 New Cardiovascular Horizons (NCVH) Annual Conference is organized by New Cardiovascular Horizons (NCVH) and will be held from Jun 01 - 04, 2021 at The Roosevelt New Orleans, A Waldorf Astoria Hotel, New Orleans, Louisiana, United States of America. This conference also available as livestream.

Target Audience:
This activity is intended for cardiologists, interventional cardiologists, vascular medicine specialists, cardiothoracic, endovascular, vascular and general surgeons, interventional radiologists, osteopaths, family physicians, internists, endocrinologists, podiatrists, physical medicine and rehabilitation, residents and fellows, diabetes & wound care specialists, advanced practice nurses, physician assistants, nurses, radiology technologists, physical therapists, paramedics, EMTs and healthcare administrators.

Accreditation:
Physicians:
Cine-Med designates this live activity for a maximum of 24.50 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:
This activity provides 24.50 contact hours for nurses.

Physician Podiatrists:
Cine-Med is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. Cine-Med has approved this activity for a maximum of 24.50 continuing education contact hours.

Overview:
This program highlights the benefits of the multidisciplinary approach to patient care, which includes primary care physicians, nurses, podiatrists, surgeons, wound care specialists and lab technicians. PAD, CLI, coronary artery disease and stroke are very complex diseases that require the collaborative efforts of a multidisciplinary team to treat successfully. The audience represents the different healthcare fields that need to come together to raise awareness among patients about CVD symptoms, the importance of follow-up care and the dangers that not seeking treatment may lead to, including stroke, amputation and death.

Learning Objectives:
At the conclusion of this activity, participants should be able to:
• Discuss the indications, risks and complications of interventional therapies in the treatment of cardiovascular disease, peripheral artery disease, and critical limb ischemia.
• Implement contemporary approaches in peripheral vascular management (including carotid, renal and mesenteric, SFA, below the knee, venous disease and aortic) based on recent clinical trials and evidenced-based data.
• Apply appropriate applications of new endovascular technologies for patients with vascular disease.
• Describe appropriate pharmacologic management in the care of patients with cardiovascular disease, peripheral artery disease and critical limb ischemia.
• Discuss various testing modalities and comprehensive spectrum of care in patients with foot ulcers and threatened limbs.
• Explain proper use and interpretation of diagnostic tools and apply appropriate screening techniques for peripheral artery disease.
• Recognize the roles and responsibilities of multidisciplinary members of a comprehensive PAD clinical team.
• Discuss and apply new trends in less invasive surgery.
• Recognize and articulate the current state of healthcare in the US: Where we are and where we are going.